Dr. Julie DiPopolo joined RG+A in early 2018. Julie is responsible for executing all phases of RG+A’s advanced and proprietary methodologies, serving as a methodological expert for clients as well as internal teams. She works to ensure that RG+A maximizes the accuracy and amount of actionable insights provided to clients from the data collected.
Immediately prior to joining RG+A, Julie worked at Nielsen where she managed a team of statisticians that supported Patient Case project work and other custom pharmaceutical primary market research studies. In her new role, she leverages her background in patient-based research and advanced analytics to ensure the accuracy of design and analysis while also working on the development of new methodologies and research approaches.
Julie has 7 years of pharmaceutical experience across multiple therapeutic areas with a focus on experimental design, discrete choice and conjoint research, segmentation.
Julie holds a B.A. in Psychology from the Richard Stockton College of NJ and a Ph.D. in Psychometrics from Fordham University.